top of page
For most cost-effective consulting services:
Click here
Home
All News
Pharma
APAC
APAC - Drug Approvals
Brazil
Canada Pharma
China Pharma
Europe Pharma
India Pharma
Japan Pharma
North America
US FDA Approvals
Therapy News
Immunology
Neurology
Oncology
Kidney Diseases
Cardiovascular
Infections_Vaccines
Metabolic Diseases
Women Health
Healthcare News
US Healthcare News
US Payer News
Europe Healthcare News
Germany Healthcare
Italy
United Kingdom Healthcare
APAC - Healthcare News
Brazil Healthcare
Healthcare Policies
Conferences
About
All Posts
Healthcare Systems
News
Conferences
Know your disease
COVID
Japan drug approvals
USA Pharma News | Healthcare News
Europe Pharma News
Japan drug approvals
Australia Pharma & Healthcare News
Canada Pharma and Healthcare News
Asia | Pharma | Healthcare News
Indication News
Latam
US FDA News
CMS News
India Drug Healthcare
China Drug Approvals
Europe Healthcare News
APAC Drug approvals
US_PayerNews
Australia TGA Approvals
Biosimilars
Radioligand therapy
Chikungunya News
NICE recommendations
G-BA Assessment Outcomes
HAS Assessment Outcomes
Neurology
Immunology
Search
Italy’s Medicine Spending Reaches €39.3 Billion in 2025 | iPharmaCenter
Badari Andukuri
1 day ago
bottom of page
